Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 16 studies | 50% ± 19% | |
chondrocyte | 4 studies | 52% ± 15% |
Insufficient scRNA-seq data for expression of COL9A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1176.67 | 2634 / 2642 | 72% | 5.78 | 508 / 705 |
prostate | 87% | 2209.64 | 212 / 245 | 46% | 2.69 | 232 / 502 |
stomach | 53% | 162.20 | 192 / 359 | 61% | 2.83 | 175 / 286 |
intestine | 43% | 116.36 | 419 / 966 | 56% | 2.64 | 293 / 527 |
bladder | 38% | 220.86 | 8 / 21 | 24% | 0.93 | 123 / 504 |
esophagus | 27% | 69.40 | 396 / 1445 | 28% | 0.81 | 52 / 183 |
ovary | 1% | 2.24 | 2 / 180 | 53% | 6.06 | 229 / 430 |
heart | 54% | 513.85 | 467 / 861 | 0% | 0 | 0 / 0 |
skin | 0% | 0.69 | 8 / 1809 | 38% | 8.22 | 178 / 472 |
thymus | 23% | 48.69 | 152 / 653 | 10% | 0.15 | 61 / 605 |
pancreas | 1% | 0.70 | 2 / 328 | 33% | 2.02 | 58 / 178 |
eye | 0% | 0 | 0 / 0 | 33% | 0.95 | 26 / 80 |
uterus | 3% | 18.19 | 5 / 170 | 15% | 3.71 | 68 / 459 |
adrenal gland | 0% | 0.52 | 1 / 258 | 13% | 0.33 | 31 / 230 |
lung | 1% | 1.82 | 3 / 578 | 11% | 0.55 | 131 / 1155 |
breast | 5% | 10.70 | 25 / 459 | 6% | 1.83 | 64 / 1118 |
kidney | 7% | 19.26 | 6 / 89 | 3% | 0.10 | 30 / 901 |
liver | 0% | 0 | 0 / 226 | 5% | 0.14 | 21 / 406 |
adipose | 3% | 5.47 | 37 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 1.55 | 13 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.34 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005594 | Cellular component | collagen type IX trimer |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | COL9A1 |
Protein name | Collagen alpha-1(IX) chain Collagen type IX alpha 1 chain Collagen type IX alpha 1 |
Synonyms | |
Description | FUNCTION: Structural component of hyaline cartilage and vitreous of the eye. |
Accessions | A0A1B1SMR9 P20849 ENST00000683980.2 ENST00000370496.3 [P20849-3] ENST00000447041.6 ENST00000683758.1 A0A804HKK1 ENST00000644493.1 A0A804HL06 ENST00000357250.11 [P20849-1] A0A804HIB6 ENST00000320755.12 [P20849-2] A0A2R8YG47 |